CD274 and leukemia: However, a few trials involve combinations with PD-1 or PD-L1 blockade (NCT03390296, NCT03969446, NCT04277442, NCT05388006 listed in https://clinicaltrials.gov) for the treatment of lymphomas or leukemias.